Activation of Akt, mTOR, and the estrogen receptor as a signature to predict tamoxifen treatment benefit.

Breast Cancer Res Treat · 2013 · PMC3539073 · PMID 23242584

Europe PMC DOI

hedged sentence

0.0640

closest p · 1.3× alpha

0.0640

boldest claim

The sentences

borderline significanceP = 0.064so close (0.05 < p ≤ 0.1)

1 c, d) and the interaction between p-mTOR and tamoxifen efficacy showed borderline significance in the latter analysis ( P = 0.064; Table 2 ).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.